Plain-English translation of NCT04408482 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
During an endoscopic procedure called ERCP, doctors sometimes need to make an opening in the pancreas to reach the bile duct. This can cause inflammation of the pancreas as a side effect. This trial is testing whether placing a small protective tube (called a pancreatic stent) can reduce the risk of this painful inflammation. Half of participants will receive the stent placement and half will not, to see which approach is safer.
Pancreatic inflammation is a common and sometimes serious complication after these procedures. Researchers want to know if the protective stent can reliably prevent this complication and improve safety for patients who need difficult bile duct treatments.
You likely qualify if…
You likely don't qualify if…
If you qualify, you will undergo your scheduled ERCP procedure. During the procedure, you will be randomly assigned to either receive a pancreatic stent or not receive one. After the procedure, doctors will monitor you for signs of pancreatic inflammation and track your recovery to see whether the stent made a difference in preventing complications.
AI-generated summary from trial data · Oct 12, 2026 · Not medical advice
Finland